PPH - (VanEck Vectors Pharmaceutical ETF)

PPHのニュース

   Quanterix Granted Breakthrough Device Designation from U.S. FDA for NfL Test for Multiple Sclerosis  2022/04/22 12:30:00 Kwhen Finance
   Quanterix Simoa® Technology Powers Latest Breakthrough in Epstein-Barr Virus and Multiple Sclerosis  2022/01/26 16:30:00 Kwhen Finance
   Quanterix Granted Breakthrough Device Designation from U.S. FDA for NfL Test for Multiple Sclerosis  2022/04/22 12:30:00 Kwhen Finance
   Quanterix Simoa® Technology Powers Latest Breakthrough in Epstein-Barr Virus and Multiple Sclerosis  2022/01/26 16:30:00 Kwhen Finance
   Alzheimers Drug Value Pushes Pharmaceutical Costs Again Into the Highlight  2021/08/05 20:05:54 FXNews24
Biogens (NASDAQ: BIIB) Aduhelm sparked a rally within the biotech larges share value and hope that progress is being made in treating Alzheimers. Nevertheless, the information is not freed from controversy, and carries with it implications for healthcare trade traded funds, together with the VanEck Vectors Pharmaceutical ETF (PPH). The $330 million PPH, as its [] The post Alzheimers Drug Value Pushes Pharmaceutical Costs Again Into the Highlight appeared first on UK Stocks, Forex, Commodities, Crypto, Live Market News- Daily Forex News .
   Alzheimers Drug Cost Pushes Pharmaceutical Prices Back Into the Spotlight  2021/08/05 16:57:09 ETF Trends
Biogens (NASDAQ: BIIB) Aduhelm sparked a rally in the biotech giants share price and hope that progress is being made in treating Alzheimers. However, the news isnt free of controversy, and carries with it implications for healthcare exchange traded funds, including the VanEck Vectors Pharmaceutical ETF (PPH). The $330 million PPH, as its name implies, [] The post Alzheimers Drug Cost Pushes Pharmaceutical Prices Back Into the Spotlight appeared first on ETF Trends .
   Quanterix Granted Breakthrough Device Designation from U.S. FDA for NfL Test for Multiple Sclerosis  2022/04/22 12:30:00 Kwhen Finance
   Quanterix Simoa® Technology Powers Latest Breakthrough in Epstein-Barr Virus and Multiple Sclerosis  2022/01/26 16:30:00 Kwhen Finance
   Alzheimers Drug Value Pushes Pharmaceutical Costs Again Into the Highlight  2021/08/05 20:05:54 FXNews24
Biogens (NASDAQ: BIIB) Aduhelm sparked a rally within the biotech larges share value and hope that progress is being made in treating Alzheimers. Nevertheless, the information is not freed from controversy, and carries with it implications for healthcare trade traded funds, together with the VanEck Vectors Pharmaceutical ETF (PPH). The $330 million PPH, as its [] The post Alzheimers Drug Value Pushes Pharmaceutical Costs Again Into the Highlight appeared first on UK Stocks, Forex, Commodities, Crypto, Live Market News- Daily Forex News .
   Alzheimers Drug Cost Pushes Pharmaceutical Prices Back Into the Spotlight  2021/08/05 16:57:09 ETF Trends
Biogens (NASDAQ: BIIB) Aduhelm sparked a rally in the biotech giants share price and hope that progress is being made in treating Alzheimers. However, the news isnt free of controversy, and carries with it implications for healthcare exchange traded funds, including the VanEck Vectors Pharmaceutical ETF (PPH). The $330 million PPH, as its name implies, [] The post Alzheimers Drug Cost Pushes Pharmaceutical Prices Back Into the Spotlight appeared first on ETF Trends .
   Former Pushpay CEO sells $6m of shares  2021/07/06 23:28:20 National Business Review
Former Pushpay CEO sells $6m of shares Fiona Rotherham 07 Jul 21

calendar